Nutex Health (NUTX) reported $875M in revenue for fiscal 2025, +82.4% year on year. That ranks #1856 by revenue among 2853 SEC filers and #327 in Technology. Net income was $70.8M, a net margin of 8.1%. Revenue has grown 273.4% a year on average since 2017 ($23,166 then). The fiscal 2025 balance sheet shows $919M in total assets, $186M in cash and $29.2M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenues | $875M | +82.4% | FY20252025-12-31 |
| Gross profitGrossProfit | $444M | +126.4% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | $276M | +110.9% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $70.8M | +35.9% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $248M | +971.7% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $2.5M | +9.6% | FY20252025-12-31 |
| Total assetsAssets | $919M | +40.2% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $329M | +148.8% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $186M | +356.6% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $29.2M | +29.9% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $216M | $46.8M | Open → |
| Q2 20262026-06-30 | $211M | $65.8M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Profile
- Legal name
- Nutex Health Inc.
- Ticker
- NUTX
- Exchange
- Nasdaq
- SIC classification
- Services-Business Services, NEC (7389)
- Fiscal year end
- 12-31
- CIK
- 0001479681
Filings
- 10-QAug 6, 2026Open filing →
- 10-QApr 30, 2026Open filing →
- 10-KMar 5, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Silicon Motion TechnologySIMO | $886M | $123M |
| WorkivaWK | $885M | −$26.2M |
| NovaNVMI | $881M | $259M |
| Nutex HealthNUTX | $875M | $70.8M |
| Rapid7RPD | $860M | $23.4M |
| Netscout SystemsNTCT | $859M | $95.5M |
| SprinklrCXM | $857M | $22.9M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Nutex Health — Key figures |url=https://companiesranked.com/en/company/nutex-health |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Nutex Health — Key figures. CompaniesRanked. https://companiesranked.com/en/company/nutex-healthBibTeX
@misc{companiesranked-en-company-nutex-health-2026,
author = {{CompaniesRanked}},
title = {{Nutex Health — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/nutex-health}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-015168 · March 5, 2026
{{cite web |title=Nutex Health — Key figures — 10-K (0001628280-26-015168) |url=https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.